Hydralazine Hydrochloride Injection
Product Images NDC 51662-1376

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 51662-1376). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Labeling (51662 1376 2 Pouch Labeling)

Label for Hydralazine Hydrochloride Injection, USP 20 mg/mL in a 1 mL vial. The label includes NDC 51662-1376-2, lot number 123456, and expiration date 2030-01-01. It indicates intramuscular and intravenous use, with storage instructions at controlled room temperature. Manufactured by HF Acquisition Co LLC, Mukilteo, WA.*

FDA Label Image

Box Labeling (51662 1376 3 Box Labeling)

Label for Hydralazine Hydrochloride Injection USP, 20 mg per mL in 1 mL vials packaged as a box of 25. The label includes NDC 51662-1376-3, lot number 123456, and expiration date 2030-01-01. It is manufactured by HF Acquisition Co LLC, DBA HealthFirst, in Mukilteo, WA. The label indicates use for intramuscular or intravenous injection and notes storage conditions and usage warnings.*

FDA Label Image

Serialized Labeling (51662 1376 3 Serialized Labeling)

A small rectangular label with a barcode and QR code, including numeric identification codes. The label states distribution by HF Acquisition Co., LLC, Mukilteo, WA 98275. The text "RX ONLY" is printed vertically on the right side.*

FDA Label Image

How Supplied (How Supplied)

A data table listing Hydralazine Hydrochloride Injection, USP at 20 mg per mL in a 1 mL fill. The product is packaged as a 2 mL single dose vial, with 25 vials per tray. It includes columns for Product No. and NDC No. with specific identifier values.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Labeling (Serialized Labeling)

HYDRALAZINE HYDROCHLORIDE Injection, USP 20 mg per mL vial for intramuscular or intravenous use. The vial features a green and purple label with dosage strength prominently displayed. Also includes a label with barcode and manufacturing information, distributed by HF Acquisition Co LLC, Mukilteo, WA.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Hydralazine Hydrochloride showing its molecular formula C8H8N4 • HCl and molecular weight 196.64.*

FDA Label Image

Vial Label (Vial Label Updated)

Label for Hydralazine Hydrochloride Injection USP, 20 mg per mL, single-dose 1 mL vial intended for intramuscular or intravenous use. The label includes a warning to discard unused portion. The labeler is Fresenius Kabi.*

FDA Label Image

Vial (Vial Labeling)

Label for Hydralazine Hydrochloride Injection USP, 20 mg per mL, in a 1 mL single dose vial. The label indicates the product is for intramuscular use only, with a warning to discard unused portions. The labeler is Fresenius Kabi.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.